Manulife stock: Insurer plans CAD 750 million subordinated issue
Published on 11/21/2026 at 11:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDebt issue sets next milestone
- Manulife announced the planned subordinated-debt offering on November 16, 2026.
- The offering is expected to close on November 23, 2026, subject to the transaction process.
- Proceeds are intended for general corporate purposes, including investments in subsidiaries and potential future redemptions.
Manulife Financial Corporation announced on Monday, November 16, that it intends to issue CAD 750 million of fixed-to-floating subordinated debentures. The planned offering is expected to close on November 23, subject to the transaction process.
The terms call for a fixed interest rate of 4.853% through November 23, 2033. The rate would then reset to 1.42% above the daily compounded Canadian Overnight Repo Rate Average, or CORRA. The debentures are scheduled to mature on November 23, 2038.
Terms shape the financing
The securities would rank equally with Manulife's other subordinated indebtedness, except for debt that is further subordinated under its terms. Manulife may redeem the debentures from November 23, 2031, subject to prior regulatory approval and the conditions described in the offering terms.
The company said it plans to use the net proceeds for general corporate purposes, including investments in subsidiaries and potential future redemptions of existing securities. The offering is being arranged on a best-efforts agency basis by a syndicate co-led by CIBC Capital Markets, RBC Capital Markets and Scotiabank.
The details were reported in a PR Newswire release carried by ABC27.
Manulife Financial Corporation
- ISIN: CA56501R1064
- Ticker: MFC
- Primary listing: Toronto Stock Exchange
- Planned financing: CAD 750 million subordinated debenture issue
- Expected closing: November 23, 2026
Broader market trading remains an important backdrop for financial stocks; see current market reports.
Further company coverage is available in more news and analyses on Manulife stock.
